Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease

Slides:

Advertisements

Similar presentations

FMRP 2014 | 1 Marc Bosiers Koen Deloose Joren Callaert A.Z. Sint-Blasius, Dendermonde Imelda Hospital, Bonheiden Patrick Peeters Jürgen Verbist OLV Hospital,

Advertisements

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty

Monica S. O'Brien-Irr, MS, RN, Hasan H. Dosluoglu, MD, Linda M

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease Gustavo S. Oderich, MD, Luke.

First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease Johannes Lammer, MD, Marc.

Outcome of infra-inguinal bypass grafts using vein conduit with less than 3 millimeters diameter in critical leg ischemia Hani Slim, MD, MRCS, Alok Tiwari,

Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease? Marc A. Passman,

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation Thomas M. Loh,

Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage Caren Randon, MD, Bart Jacobs, MD, Frederik.

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Michael C. Stoner, MD, Dorian J. deFreitas, MD, Sachin V

Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions Michele.

Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia Francesco A. Aiello, MD, Asad A.

Collateral artery from arteriovenous malformation of the rectum in a patient with peripheral artery disease Hirotomo Uchiyama, MD, Reiji Hattori, MD,

Michael S. Conte, MD Journal of Vascular Surgery

An analysis of IN.PACT DEEP randomized trial on the limitations of the societal guidelines-recommended hemodynamic parameters to diagnose critical limb.

Bifurcated coronary stents for infrapopliteal angioplasty in critical limb ischemia Roberto Silingardi, MD, Sebastiano Tasselli, MD, Valentina Cataldi,

Insulin use is associated with poor limb salvage and survival in diabetic patients with chronic limb ischemia Hasan H. Dosluoglu, MD, Purandath Lall,

Changing pattern of surgical revascularization for critical limb ischemia over 12 years: Endovascular vs open bypass surgery Toshifumi Kudo, MD, PhD,

Infected aneurysm of the thoracic aorta

Changing demographics in patients with vascular disease

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arterial disease: A meta-analysis of randomized trials Ridong Wu, MD,

Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience Marvin D. Atkins, MD, Christopher J.

Infrainguinal angioplasty with drug-eluting stents and balloons

Christopher J. Smolock, MD, Javier E

Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia Christopher.

Virendra I. Patel, MD, Mark F. Conrad, MD, Christopher J

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Outcomes of reinterventions after subintimal angioplasty

Syed N. Haider, Eamon G. Kavanagh, MD, Martin Forlee, FCS (SA), Mary P

Open versus endoscopic great saphenous vein harvest for lower extremity revascularization of critical limb ischemia Vincent J. Santo, MD, Phong T. Dargon,

Comparison of the vascular responses to balloon-expandable stenting in the coronary and peripheral circulations: Long-term results in an animal model.

Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis Monika Herten, PhD, Giovanni.

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

Initial and 3-year results after subintimal versus intraluminal approach for long femoropopliteal occlusion treated with a self-expandable nitinol stent

Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease Shant M. Vartanian, MD, Paul C. Johnston, MD, Joy.

A comparison of percutaneous transluminal angioplasty versus amputation for critical limb ischemia in patients unsuitable for open surgery Spence M.

Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé.

Sadaf S. Ahanchi, MD, Christopher L. Stout, MD, Tyler J

Stent placement for treatment of central and peripheral venous obstruction: A long-term multi-institutional experience Gustavo S.C. Oderich, MD, Gerald.

Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease Tzu-Ting Kuo, MD, Po-Lin Chen, MD, Chun-Yang.

Primary stenting of the superficial femoral and popliteal artery

Subclavian revascularization in the age of thoracic endovascular aortic repair and comparison of outcomes in patients with occlusive disease Salvatore.

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease Robert W. Chang, MD, Philip P. Goodney,

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Soma Brahmanandam, MD, MPH, Eric L. Ding, ScD, Michael S

Wei Zhou, MD, Peter H. Lin, MD, Ruth L. Bush, MD, Eric K

Plaque excision with the Silverhawk catheter: Early results in patients with claudication or critical limb ischemia W. Brent Keeling, MD, Murray L. Shames,

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage Andrea E. Yancey, MD, David J. Minion,

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

First-in-human study of the INCRAFT endograft in patients with infrarenal abdominal aortic aneurysms in the INNOVATION trial Dierk Scheinert, MD, PhD,

Surgical management of severe acute lower extremity ischemia

Early results of stent-grafting to treat diffuse aortoiliac occlusive disease Eva M Rzucidlo, MD, Richard J Powell, MD, Robert M Zwolak, MD, PhD, Mark.

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Differences in anatomy and outcomes in patients treated with open mesenteric revascularization before and after the endovascular era Evan J. Ryer, MD,

Ten-year technical and clinical outcomes in TransAtlantic Inter-Society Consensus II infrainguinal C/D lesions using duplex ultrasound arterial mapping.

Endovascular interventions for TASC II D femoropopliteal lesions

Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia Bram Fioole, MD, PhD, Hendrik.

Surgical versus endovascular repair by iliac branch device of aneurysms involving the iliac bifurcation Konstantinos P. Donas, MD, PhD, Giovanni Torsello,

Surgical management of popliteal artery aneurysms: Which factors affect outcomes? Raffaele Pulli, MD, Walter Dorigo, MD, Nicola Troisi, MD, Alessandro.

Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for patients with post-carotid endarterectomy stenosis Ali F. AbuRahma,

Presentation transcript:

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease Marc Bosiers, MD, Dierk Scheinert, MD, Patrick Peeters, MD, Giovanni Torsello, MD, Thomas Zeller, MD, Koen Deloose, MD, Andrej Schmidt, MD, Jörg Tessarek, MD, Erwin Vinck, Lewis B. Schwartz, MD Journal of Vascular Surgery Volume 55, Issue 2, Pages 390-398 (February 2012) DOI: 10.1016/j.jvs.2011.07.099 Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 1 Primary patency of infrapopliteal lesions treated in the DESTINY trial. The difference in patency between the Vision and Xience V groups was highly statistically significant (P = .001). Journal of Vascular Surgery 2012 55, 390-398DOI: (10.1016/j.jvs.2011.07.099) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 2 Freedom from target lesion revascularization (TLR) of infrapopliteal lesions treated in the DESTINY trial. The difference in TLR between the Vision and Xience V groups was highly statistically significant (P = .001). Journal of Vascular Surgery 2012 55, 390-398DOI: (10.1016/j.jvs.2011.07.099) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 3 Clinical outcome of patients treated in the DESTINY trial by Rutherford class. The top panel represents the Vision group and the bottom panel represents the Xience V group. Journal of Vascular Surgery 2012 55, 390-398DOI: (10.1016/j.jvs.2011.07.099) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 4 Survival of patients treated in the DESTINY trial. There was no observed difference in survival between the Vision and Xience V groups (P = .96). Journal of Vascular Surgery 2012 55, 390-398DOI: (10.1016/j.jvs.2011.07.099) Copyright © 2012 Society for Vascular Surgery Terms and Conditions